Santen Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
76,984
66,110
100,032
53,297
69,283
70,796
Total Accounts Receivable
53,986
61,701
65,998
70,970
78,654
84,618
Inventories
19,461
20,133
24,996
28,502
30,636
35,235
Other Current Assets
2,810
2,728
3,713
4,242
4,794
4,093
Total Current Assets
153,241
150,672
194,739
157,011
183,367
194,742
Net Property, Plant & Equipment
27,175
29,104
27,991
28,550
29,706
31,699
Total Investments and Advances
23,334
34,725
44,535
29,889
35,775
30,044
Intangible Assets
26,610
84,433
83,681
138,935
134,495
131,110
Other Assets
2,065
2,288
2,108
2,124
2,855
1,819
Total Assets
237,640
304,200
355,399
358,906
388,463
391,186
ST Debt & Current Portion LT Debt
51
11,810
9,540
9,331
4,098
Accounts Payable
19,072
20,250
17,225
17,883
22,471
Income Tax Payable
8,081
6,729
20,431
3,279
7,656
Other Current Liabilities
11,982
17,551
26,034
22,988
27,976
Total Current Liabilities
39,186
56,340
73,230
53,481
62,201
Long-Term Debt
102
25,351
12,944
7,598
3,500
Provision for Risks & Charges
6,868
6,903
4,185
3,326
3,171
Deferred Taxes
2,420
104
1,643
15,567
10,645
Other Liabilities
1,479
953
1,043
20,609
19,123
Total Liabilities
50,430
92,421
95,390
102,977
100,904
Common Equity (Total)
187,210
211,779
260,009
255,110
285,823
Total Shareholders' Equity
187,210
211,779
260,009
255,110
285,823
Total Equity
187,210
211,779
260,009
255,929
287,557
Liabilities & Shareholders' Equity
237,640
304,200
355,399
358,906
388,461
Accumulated Minority Interest
-
-
-
819
1,734
About Santen Pharmaceutical Co.
View Profile
